| Oral bioavailability in rat at 10 mg/kg - BioAssay Summary Thermosensitive transient receptor potential melastatin 8 (TRPM8) antagonists are considered to be potential therapeutic agents for the treatment of cold hypersensitivity. The discovery of a new class of TRPM8 antagonists that shows in vivo efficacy in the rat chronic constriction injury (CCI)-induced model of neuropathic pain is described. ..more |
_ | |
||||||||||||||||||||||||||||||||||||||||||||||||
Tested Compound: Description: Title: Discovery of vinylcycloalkyl-substituted benzimidazole TRPM8 antagonists effective in the treatment of cold allodynia. Abstract: Thermosensitive transient receptor potential melastatin 8 (TRPM8) antagonists are considered to be potential therapeutic agents for the treatment of cold hypersensitivity. The discovery of a new class of TRPM8 antagonists that shows in vivo efficacy in the rat chronic constriction injury (CCI)-induced model of neuropathic pain is described. (PMID: 22330635) Comment Putative Target: ChEMBL Target ID: 50597 Target Type: ORGANISM Pref Name: Rattus norvegicus Organism: Rattus norvegicus Tax ID: 10116 Confidence: Target assigned is non-molecular Relationship Type: Non-molecular target assigned Categorized Comment ChEMBL Assay Type: ADMET ChEMBL Assay Data Source: Scientific Literature ChEMBL Assay Test Type: In vivo Result Definitions
Data Table (Concise)
PageFrom: |
||||||||||||||||||||||||||||||||||||||||||||||||||